GOLDMAN SACHS GROUP INC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$3,722,956
+6.2%
361,452
+69.9%
0.00%0.0%
Q2 2023$3,506,928
+631.1%
212,799
+306.4%
0.00%
Q1 2023$479,691
+136.6%
52,368
+84.9%
0.00%
Q4 2022$202,757
+28.3%
28,318
-9.9%
0.00%
Q3 2022$158,000
+209.8%
31,444
+51.2%
0.00%
Q2 2022$51,000
-83.4%
20,798
-53.7%
0.00%
Q1 2022$307,000
-33.4%
44,946
-21.2%
0.00%
Q4 2021$461,000
+16.7%
57,003
+41.3%
0.00%
Q3 2021$395,000
+70.3%
40,349
+16.9%
0.00%
Q2 2021$232,000
+29.6%
34,515
+73.8%
0.00%
Q1 2021$179,000
-64.5%
19,854
-73.7%
0.00%
Q4 2020$504,000
+300.0%
75,375
+202.0%
0.00%
Q3 2020$126,000
-96.4%
24,959
-94.3%
0.00%
-100.0%
Q1 2020$3,505,000
+8448.8%
441,440
+2659.0%
0.00%
Q4 2018$41,000
-55.4%
16,000
-23.4%
0.00%
Q3 2018$92,000
-60.0%
20,877
-44.2%
0.00%
Q2 2018$230,000
+19.2%
37,447
+41.3%
0.00%
Q1 2018$193,000
-10.6%
26,510
+0.8%
0.00%
Q4 2017$216,000
-41.5%
26,298
-25.2%
0.00%
Q3 2017$369,000
+0.5%
35,159
+5.7%
0.00%
Q2 2017$367,000
-50.7%
33,271
-56.8%
0.00%
Q1 2017$745,00076,9380.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders